Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CAP, adenylate cyclase-associated protein 1 pseudogene 2 (CAP1P2)
- Target
- CAP1P2
- Molecular classification
- Other (Pseudogene)
01
Overview
CAP1 pseudogene 2 (CAP1P2) is a human pseudogene related to the protein-coding gene CAP1 (Cyclase Associated Actin Cytoskeleton Regulatory Protein 1). Pseudogenes are inheritable genetic elements that resemble protein-coding genes but carry disabling mutations and typically do not produce functional proteins. CAP1P2 is classified as a pseudogene and is not known to produce a functional product or to have therapeutic target potential. There is no evidence to indicate CAP1P2 has any direct biological function, disease association, or relevance as a drug target. Its primary relevance is limited to its sequence homology with the protein-coding CAP1 gene. CAP1P2 is a nonfunctional genetic element with no established biological role, protein product, or pharmacological relevance. No drugs, biomarkers, or safety concerns are associated with this pseudogene. Its inclusion in therapeutic target lists is incorrect.
- Other names
- CAP1P2CAP, adenylate cyclase-associated protein 1 pseudogeneCAP1 pseudogene 2
Beyond the preview
Go deeper on CAP, adenylate cyclase-associated protein 1 pseudogene 2 (CAP1P2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CAP, adenylate cyclase-associated protein 1 pseudogene 2 (CAP1P2).